REQUEST A DEMO
Total
USD $0.00
Search more companies

PETA Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Electronic Shopping and Mail-Order Houses
Full name: PETA Pharma Kft. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

PETA Pharma Kft. is an enterprise in Hungary, with the main office in Siofok. It operates in the Pharmacies and Drug Stores sector. PETA Pharma Kft. was incorporated on June 01, 2010. There are currently 13 (2026) people employed by PETA Pharma Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 8.81% in 2025. Its total assets grew by 12.92% over the same period. The net profit margin of PETA Pharma Kft. increased by 2.24% in 2025.

Headquarters
Zamardi utca 4.
Siofok; Siofok; Postal Code: 8600

Contact Details: Purchase the PETA Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the PETA Pharma Kft. report to view the information.
Registered Capital:
Purchase the PETA Pharma Kft. report to view the information.
Financial Auditors:
Purchase the PETA Pharma Kft. report to view the information.
Incorporation Date:
June 01, 2010
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Petagrande Estate Kft.
Company Performance
Financial values in the chart are available after PETA Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.81%
Total Operating Revenue
6.94%
Operating Profit
75.97%
EBITDA
48.03%
Net Profit/Loss for the Period
70.87%
Total Assets
12.92%
Total Equity
19.32%
Operating Profit Margin
2.56%
Net Profit Margin
2.24%
Return on Equity (ROE)
4.89%
Debt / Equity
-0.74%
Quick Ratio
0.66%
Cash Ratio
0.62%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?